Minneapolis Clinical Trials
Activation Study
Purpose: to evaluate the safety and tolerability of a potential new drug for the purpose of treating various autoimmune and inflammatory diseases
8 nights
1 visits
Participate in a clinical study of a potential treatment for various autoimmune and inflammatory diseases.
This study has 1 screening appointment and 8 nights/ 9 days inpatient stay.
Reimbursement for study participation will be provided for time and travel of up to $4,900.
Participants will dose 4 times in this study to evaluate crystalline formulation tablet versus reference tablet in fed and fasted conditions.
This study has been reviewed by an Institutional Review Board.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-55
BMI: 18-32kg/m2
Medication: All medications (including St. John’s Wort or ginseng) must be avoided for 14 days before admission except for aspirin/ibuprofen, hormonal contraception, and menopausal hormone replacement therapy)
Smoking Status: Non-smokers, or no more than 1 cigarettes per day are allowed, must be willing to refrain during study
Contraception: Must be willing to follow contraception requirements for the study
Compensation: Up to $4,900